LUMO - Lumos Pharma Announces Participation in Investor Conferences in September | Benzinga
AUSTIN, Texas, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for moderate Pediatric Growth Hormone Deficiency (PGHD) through Phase 2 clinical trials, announced that the Company will participate in the H.C. Wainwright 25th Annual Global Investment Conference being held September 11th – 13th and the Cantor Global Healthcare Conference 2023 being held September 26th – 28th in New York City. Lumos Pharma management will present and host one-on-one meetings at both conferences.
H.C. Wainwright 25th Annual Global Investment Conference: September 11th – 13th
Title: |
Lumos Pharma Corporate Presentation (On-Demand) |
Date/Time: |